ISSN: 2375-3838
International Journal of Clinical Medicine Research  
Manuscript Information
 
 
Awareness of Dengue Virus in Professionals and General Public
International Journal of Clinical Medicine Research
Vol.1 , No. 4, Publication Date: Sep. 16, 2014, Page: 121-124
1988 Views Since September 16, 2014, 865 Downloads Since Apr. 14, 2015
 
 
Authors
 
[1]    

Safila Naveed, Faculty of Pharmacy Jinnah University for women, Karachi, Pakistan; Faculty of pharmacy, University of Karachi, Karachi, Pakistan.

[2]    

Sidra Ghayas, Faculty of Pharmacy Jinnah University for women, Karachi, Pakistan; Faculty of pharmacy, University of Karachi, Karachi, Pakistan.

[3]    

Asra Hameed, Faculty of Pharmacy Jinnah University for women, Karachi, Pakistan.

[4]    

Noureena Hanif, Faculty of Pharmacy Jinnah University for women, Karachi, Pakistan.

 
Abstract
 

A viral infectious disease, dengue which is transmitted by mosquitoes, is very severe disease. Symptoms may vary person to person and also depends upon the severity of the viral infection. High fever, headache and body aches are the general complains of dengue infectious patients. Thrombocytopenia is also common in dengue. There is no treatment of this viral infection. Avoid of aspirin, use of acetaminophen (paracetamol), rest and use of plenty of water and other drinks or juices may recover the infectious person within 7-14days. Prevention of this infectious disease is must like use of insecticidal, mosquito repellents, covering of clean water, full body covering dresses and avoid open places like parks in morning and evening times proved very much effective in order to prevent this infectious disease. Our study aims to find out its awareness among the general public as well as among the professionals. Data was collected randomly in Karachi city. All the important questions were asked during our survey. 50males and 50 females were selected from general public. Males have on average of 5.96% awareness about the dengue whereas females on average have 5.64%. Data was also collected from professionals in whom 24 pharmacists and 30 microbiologists were selected randomly. Pharmacists have on average of 5.5 percent awareness about the dengue whereas other professionals (microbiologists) on average have 5.4 percent awareness of dengue.


Keywords
 

Viral Infection, Mosquito, Professionals, Pharmacist, Microbiologist


Reference
 
[01]    

Guha-Sapir, D., and B. Schimmer. 2005. Dengue fever: new paradigms for a changing epidemiology. Emerg. Themes Epidemiol. 2:1.

[02]    

Harris, E., E. Videa, L. Perez, E. Sandoval, Y. Tellez, M. L. Perez, R. Cuadra, J. Rocha, W. Idiaquez, R. E. Alonso, M. A. Delgado, L. A. Campo, F. Acevedo, A. Gonzalez, J. J. Amador, and A. Balmaseda. 2000. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am. J. Trop. Med. Hyg. 63:5-11

[03]    

Carlos, C. C., K. Oishi, M. T. Cinco, C. A. Mapua, S. Inoue, D. J. Cruz, M. A. Pancho, C. Z. Tanig, R. R. Matias, K. Morita, F. F. Natividad, A. Igarashi, and T. Nagatake. 2005. Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines. Am. J. Trop. Med. Hyg. 73:435-440.

[04]    

Guzman, M. G., G. Kouri, J. Bravo, L. Valdes, S. Vazquez, and S. B. Halstead. 2002. Effect of age on outcome of secondary dengue 2 infections. Int. J. Infect. Dis. 6:118-124.

[05]    

Kittigul, L., P. Pitakarnjanakul, D. Sujirarat, and K. Siripanichgon. 2007. The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection. J. Clin. Virol. 39:76-81.

[06]    

Nguyen, T. H., H. Y. Lei, T. L. Nguyen, Y. S. Lin, K. J. Huang, B. L. Le, C. F. Lin, T. M. Yeh, Q. H. Do, T. Q. Vu, L. C. Chen, J. H. Huang, T. M. Lam, C. C. Liu, and S. B. Halstead. 2004. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J. Infect. Dis. 189:221-232.

[07]    

Anonymous. 1986. Dengue hemorrhagic fever, diagnosis, treatment and control. World Health Organization, Geneva, Switzerland.

[08]    

Hayes, E. B., and D. J. Gubler. 1992. Dengue and dengue hemorrhagic fever. Pediatr. Infect. Dis. J. 11:311–317.

[09]    

Sabin, A. B. 1952. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1:30–50.

[10]    

Siler, J. F., M. W. Hall, and A. Hitchens. 1926. Dengue, its history, epidemiology, mechanism of transmission, etiology, clinical manifestations, immunity and prevention. Philipp. J. Sci. 29:1–304.

[11]    

Waterman, S. H., and D. J. Gubler. 1989. Dengue fever. Clin. Dermatol. 7:117–122.

[12]    

Dietz, V., D. J. Gubler, S. Ortiz, G. Kuno, A. Casta-Velez, G. E. Sather, I. Gomez, and E. Vergne. 1996. The 1986 dengue and dengue hemorrhagic fever epidemic in Puerto Rico: epidemiologic and clinical observations. P. R. Health Sci. J. 15:201–210.

[13]    

B. A. Wills, N. M. Dung, H. T. Loan et al., “Comparison of three fluid solutions for resuscitation in dengue shock syndrome,” The New England Journal of Medicine, vol. 353, no. 9, pp. 877–889, 2005.

[14]    

C. C. Michel and F. E. Curry, “Microvascular permeability,” Physiological Reviews, vol. 79, no. 3, pp. 703–761, 1999. View at Scopus

[15]    

V. H. Huxley and F. E. Curry, “Differential actions of albumin and plasma on capillary solute permeability,” American Journal of Physiology, vol. 260, no. 5, pp. H1645–H1654, 1991.

[16]    

B. A. Wills, E. E. Oragui, M. D. Nguyen et al., “Size and charge characteristics of the protein leak in dengue shock syndrome,” Journal of Infectious Diseases, vol. 190, no. 4, pp. 810–818, 2004.

[17]    

P. Avirutnan, N. Punyadee, S. Noisakran et al., “Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement,” Journal of Infectious Diseases, vol. 193, no. 8, pp. 1078–1088, 2006.

[18]    

P. Avirutnan, A. Fuchs, R. E. Hauhart et al., “Antagonism of the complement component C4 by flavivirus nonstructural protein NS1,” The Journal of Experimental Medicine, vol. 207, no. 4, pp. 793–806, 2010.

[19]    

P. Avirutnan, L. Zhang, N. Punyadee et al., “Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E,” PLoS Pathogens, vol. 3, no. 11, article e183, 2007.

[20]    

By Varnada Karriem-Norwood, MD on September 20, 2012 WebMD, LLC. http://www.webmd.com/a-to-z-guides/dengue-fever-reference?page=2

[21]    

Dengue: guidelines for diagnosis, treatment, prevention and control -- New edition., Chapter 2: Clinical management and delivery of clinical services, PAGE-45, ISBN 978 92 4 154787 1, by Dr Jacqueline Deen, Dr Lucy Lum, Dr Eric Martinez, Dr Lian Huat Tan.

[22]    

Gubler, D. J. 1987. Dengue and dengue hemorrhagic fever in the Americas. P. R. Health Sci. J. 6:107–111.

[23]    

Gubler, D. J. 1993. Dengue and dengue hemorrhagic fever in the Americas, p. 9–22. In P. Thoncharoen (ed.), Monograph on dengue/dengue hemorrhagic fever. W.H.O. regional publication SEARO no. 22. World Health Organization, New Delhi, India.

[24]    

Gubler, D. J. 1997. Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem, p. 1–22. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CAB International, London, United Kingdom.

[25]    

Gubler, D. J. The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future. Ann. Acad. Med. Singapore, in press.

[26]    

Gubler, D. J., and G. G. Clark. 1995. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg. Infect. Dis. 1:55–57.

[27]    

Gubler, D. J., and D. W. Trent. 1994. Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas.Infect. Agents Dis. 2:383–393.

[28]    

Halstead, S. B. 1980. Dengue hemorrhagic fever—public health problem and a field for research. Bull. W. H. O. 58:1–21.

[29]    

Halstead, S. B. 1992. The XXth century dengue pandemic: need for surveillance and research. Rapp. Trimest. Stat. Sanit. Mond. 45:292–298.

[30]    

Monath, T. P. 1994. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA 91:2395–2400.

[31]    

Gubler, D. J. 1988. Dengue, p. 223–260. In T. P. Monath (ed.), Epidemiology of arthropod-borne viral diseases. CRC Press, Inc., Boca Raton, Fla.

[32]    

Gubler, D. J., and A. Casta-Velez. 1991. A program for prevention and control of epidemic dengue and dengue hemorrhagic fever in Puerto Rico and the U.S. Virgin Islands. Bull. Pan Am. Health Org. 25:237–247.

[33]    

Gubler, D. J. 1989. Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up. Am. J. Trop. Med. Hyg. 40:571–578.

[34]    

Safila Naveed .2014 A Survey Study on awareness of Hepatitis C in different groups. World journal of pharmaceutical Sciences ISSN 2321-331:02(5): 449-454

[35]    

Safila Naveed, et al.2014 Knowledge and Attitude about Crimean Congo Hemorrhagic Fever (CCHF) Amongst Local Residents Of Karachi, PAKISTAN Accepted J App Pharm Vol. 6; Issue 2: 166-170

[36]    

Safila Naveed, 2014 Frequency Of Diabetes In Different Age Groups of Karachi DHR International Journal Of Medical Sciences (DHR-IJMS) ISSN: 2278-831X, Vol. 5(1), 61-64.

[37]    

Safila Naveed, Ayesha Siddiqui, Aqdas Rais, Sarah Usman, Syeda Irma Zaidi, Syeda Wasiqa (2014) General Awarnance Of Human Papilloma Virus Vaccine Against Cervical Cancer. MJPMS Mintage journal of Medical and pharmaceutical Sciences Vol 3 Issue 1,11-14.





 
  Join Us
 
  Join as Reviewer
 
  Join Editorial Board
 
share:
 
 
Submission
 
 
Membership